Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2R44AA026234-02 | U.S. NIH Grant/Contract | View source | |
| 5R44AA026234-03 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| RAND | OTHER |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | NIH |
Not provided
Not provided
Not provided
Not provided
This Phase II Small Business Innovative Research (SBIR) project is a clinical effectiveness and cost-effectiveness random controlled trial (RCT) of DynamiCare Health's innovative smartphone/smart debit card remote digital coaching program, which integrates Contingency Management, Recovery Coaching, and cognitive behavioral therapy (CBT), to address alcohol use disorder (AUD) in 300 adults.
This application proposes to continue clinical effectiveness and cost-effectiveness testing of the DynamiCare Health platform. This is an innovative smartphone-based digital coaching program that offers remotely-delivered contingency management (CM), Recovery Coaching, and cognitive behavioral therapy (CBT) content to address alcohol use disorder (AUD). CM, which uses financial incentives to reward abstinence and treatment attendance, is one of the most effective, evidence-based, and overlooked intervention for substance use disorders (SUD). DynamiCare, through its remote delivery system, has addressed the logistical barriers to adoption, and now seeks, through this proposal, to drive payer adoption. Our Phase 1 preliminary data shows that the intervention is acceptable and can be highly effective when delivered as a supplemental therapy to persons with AUD enrolled in treatment. Phase 2 proposes to partner with Medicaid to deploy and test the fully developed intervention in an RCT among individuals with AUD (n=300). Our goals are to: 1) Deploy the DynamiCare CM and digital coaching program at scale among Medicaid members with AUD; 2) determine clinical effectiveness; and 3) evaluate the cost-effectiveness and return-on-investment from the payer perspective. This study design addresses a lack in the CM literature of empirical evidence on the cost-savings for payers from CM. If CM can be shown to create cost-savings for payers, the final barrier to widespread adoption would fall. Overall, this Phase 2 project, which follows a highly successful Phase 1, will provide critical data to advance the utility of this innovative digital platform as it is deployed in the real world to help the millions of people with AUD.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| DynamiCare Motivation Support Program | Experimental | Intervention Group members will receive 32 weeks of remote Contingency Management (CM; financial motivational incentives), Recovery Coaching, substance testing, appointment reminding/tracking, and in-app Cognitive Behavioral Therapy (CBT). After 32 weeks, coaching, testing, appointment tracking and CBT will continue until an overall 12 months in the project is completed. |
|
| Untreated or Routine Care Control Group | Other | Control participants will receive substance tests at the same frequency as Intervention participants, and the same incentive amounts for tests as treatment participants. Controls' payments, however, will not be contingent on positive/negative results, but rather only on valid, on-time submission. Controls will not receive coaching, CBT or rewards for appointments. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DynamiCare Motivation Support Program | Combination Product | DynamiCare is an evidence-based, multi-service platform that combines software, smartphone and pocket-sized alcohol and drug testing hardware, and recovery services, designed to remotely deliver evidence-based methodologies to facilitate people's motivation and accountability to overcome alcohol, nicotine and other drug use disorders, whether in formal treatment or not. |
| Measure | Description | Time Frame |
|---|---|---|
| Alcohol Use | The primary outcome measure is alcohol use, in terms of the number of weeks of abstinence confirmed by DynamiCare Breathalyzer tests and self-report. | 32 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Engagement | Percent of available funds earned as a composite measure. | 32 weeks |
| Retention | Monthly rates of retention in the program. |
Not provided
Inclusion Criteria:
Participants in the study must have Alcohol Use Disorder (AUD) and:
Exclusion Criteria:
All genders are eligible
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eric E Gastfriend, MBA | DynamiCare Health Inc. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| DynamiCare Health | Boston | Massachusetts | 02109 | United States |
Not provided
| Label | URL |
|---|---|
| Press release describing study launch and Vermont Medicaid's Chief Medical Officer's rationale. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Apr 13, 2026 | |
| Reset | Apr 30, 2026 | |
| Release | May 20, 2026 | |
| Reset | Jun 15, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Apr 13, 2026 | Apr 30, 2026 | |||
| May 20, 2026 |
| ID | Term |
|---|---|
| D000437 | Alcoholism |
| D019966 | Substance-Related Disorders |
| D016739 | Behavior, Addictive |
| ID | Term |
|---|---|
| D019973 | Alcohol-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D003192 | Compulsive Behavior |
Not provided
Not provided
Random-controlled trial
Not provided
Not provided
Not provided
Not provided
|
| Untreated or Routine Care Control Group | Other | No specific intervention, i.e., research participation plus any community-based treatment the individual seeks to obtain. |
|
| 32 weeks |
| Drug Use Clinical Effectiveness | Measured by DynamiCare saliva drug test results and weekly self-report. | 32 weeks |
| Cost-effectiveness | Medicaid healthcare utilization claims costs vs. prior 12 months. | 12 months |
| Jun 15, 2026 |
| D007175 | Impulsive Behavior |
| D001519 | Behavior |